KSQ Therapeutics


KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed.

Employees

11-50

Links


Org chart

Collapse
Chris Heberlig
Chief Financial Officer
Thomas Leitch
Chief Technology Officer
Micah Benson
Chief Scientific Officer
Patricia Harris
Senior Vice President

Board & advisors

Alan Crane
Board Member
Richard Moscicki
Board Member
Doug Cole
Board Member
Frank Stegmeier
Board Member
Mahesh Karande
Board Member